Gain Therapeutics, Inc. — Investor Relations & Filings
Gain Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops next-generation allosteric small molecule therapies. The company utilizes its proprietary Magellan™ drug discovery platform, which combines artificial intelligence with physics-based computational models to identify novel allosteric binding sites on disease-implicated proteins. This approach aims to modulate protein function to treat diseases that are currently undruggable. The company's lead candidate, GT-02287, is in Phase I clinical trials for the treatment of GBA-Parkinson’s disease. Gain's therapeutic pipeline targets neurodegenerative diseases, lysosomal storage disorders, and other conditions with high unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-26 | English | |
| DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 47063407 | FORM 8-K | 2026-05-26 | English | ||
| 38172661 | DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | ||
| 33053358 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 33053356 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 32975364 | 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | ||
| 31868801 | 8-K Filing | 2026-02-03 | English | ||
|
2025
9 filings
| |||||
| 13280065 | FORM 8-K | 2025-12-18 | English | ||
| 13280066 | FORM S-8 | 2025-12-03 | English | ||
| 13280067 | FORM 8-K | 2025-11-28 | English | ||
| 13280068 | 424B5 | 2025-11-28 | English | ||
| 13280071 | 10-Q | 2025-11-12 | English | ||
| 13280070 | 8-K | 2025-11-12 | English | ||
| 13280069 | S-3/A | 2025-11-07 | English | ||
| 13280072 | FORM 8-K | 2025-10-14 | English | ||
| 13280073 | FORM 8-K | 2025-10-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
Gain Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gain Therapeutics, Inc. (id: 34440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.